How TG2 Affects Astrocytes and Nerve Recovery
New research reveals TG2's role in astrocyte behavior and nerve cell support.
Thomas Delgado, Jacen Emerson, Matthew Hong, Jeffrey W. Keillor, Gail VW Johnson
― 7 min read
Table of Contents
- The Role of TG2 in Astrocytes
- Testing Neuron Growth in the Lab
- The Effects of VA4 on Astrocytes
- Getting into the Details of the Research
- Analyzing Neuron Growth
- Investigating Protein Interactions
- Looking at Histone Acetylation
- Effects of VA4 on Histone Acetylation
- Protein Analysis to Understand Changes
- Summary of Findings
- Why This Matters
- Conclusion
- Original Source
- Reference Links
Astrocytes are special cells found in the brain and spine. They do a lot of important jobs to keep our nervous system healthy. When everything is normal, astrocytes help protect the brain's blood supply, support nearby nerve cells, and make sure everything runs smoothly. But when they face stress from injuries or infections, they can change their behavior. Sometimes they help protect the brain, and sometimes, less happily, they can do the opposite and cause harm.
The Role of TG2 in Astrocytes
One of the key players in these changes is a protein called transglutaminase 2, or TG2 for short. This protein is found throughout the brain and has many tasks. Typically, it helps build connections between proteins and can also affect how astrocytes behave during times of stress. When astrocytes are stressed, TG2 can change their function, but scientists are still trying to figure out all the details of how this happens.
Our team has discovered that TG2 can be a big deal in how astrocytes react during stressful times. When TG2 is deleted or stopped from working, astrocytes can actually become better at supporting the survival of nearby nerve cells. In experiments, we found that when we knock out TG2 in mice, those animals recover faster after injuries to their spinal cords than regular mice with TG2.
Testing Neuron Growth in the Lab
To dig deeper into how TG2 affects astrocytes, we set up tests to see how they help nerves grow when there's an injury. We created a tough environment for nerve cells to grow, using something called chondroitin sulfate proteoglycans (CSPGs). CSPGs are known to get in the way of nerve growth after spinal cord injuries. When we looked at how well nerves grew on this CSPG-rich surface with astrocytes that lacked TG2, we noticed that the ones without TG2 helped the nerves grow much better than those with TG2.
This gave us a cool idea: if TG2 is involved in blocking nerve growth, removing it might help nerves recover better after injuries. But, we still don’t know all the tiny details about how exactly this works.
The Effects of VA4 on Astrocytes
To better understand TG2's role, we used a special drug called VA4 that inhibits TG2. This drug works by changing TG2's shape and preventing it from doing its usual job. It’s kind of like putting a “Do Not Enter” sign on TG2.
When we treated astrocytes from normal mice with VA4, we found that these cells behaved similarly to the ones lacking TG2. In various tests, both kinds of astrocytes showed more ability to survive under stress and do a better job supporting neighboring nerve cells. This discovery shows that blocking TG2 can help astrocytes adapt in a way that makes them more supportive.
Getting into the Details of the Research
To make sure our findings were reliable, we closely followed specific methods with our lab animals. All our mice and rats lived in comfortable conditions and we made sure to stick to the rules for using animals in research.
We used normal mice and a special group of mice that lacked TG2. To study astrocytes, we took brain cells from very young mice and grew them under controlled conditions. We treated these cells with VA4 or DMSO (a control substance) to see how they react.
We also looked at how Neurons grew when paired with astrocytes treated with VA4. This gave us insight into how astrocytes influence nerve growth and recovery.
Analyzing Neuron Growth
In our key experiments, we looked at how well nerves developed when paired with astrocytes. We used different materials to encourage or block growth, and we analyzed how the nerves looked under a microscope after being treated with VA4 or DMSO.
Surprisingly, we found that astrocytes treated with VA4 helped nerves grow longer than the ones treated with DMSO. This means that blocking TG2 improves the growth of nerve cells in environments that typically inhibit growth.
Investigating Protein Interactions
Another interesting part of our research was examining how TG2 interacts with another important protein called Zbtb7a. This protein is like a traffic cop for genes, helping to control which ones get turned on or off. We wanted to see if the interaction between TG2 and Zbtb7a changes when we treat the astrocytes with VA4.
Using a technique called immunoprecipitation, we found that when we blocked TG2 with VA4, it pulled in less Zbtb7a than when TG2 was working normally. This suggests that TG2 stops Zbtb7a from doing its job when it's active.
Histone Acetylation
Looking atBesides those interactions, we also examined the roles of histones, which are proteins that help package DNA in cells. We focused on a specific modification called acetylation, which usually means that a gene is more likely to be active and ready to be used.
When we compared the levels of acetylated histones in normal astrocytes with those lacking TG2, we saw that the latter had significantly higher levels of acetylation. This tells us that without TG2, astrocytes are more ready to turn on genes that help them respond positively to stress.
Effects of VA4 on Histone Acetylation
We were curious whether VA4 treatment would also increase acetylation levels in normal astrocytes. Sure enough, we found that astrocytes treated with VA4 had higher acetylation levels, similar to those with TG2 deleted. This suggests that when we block TG2, it eases the restrictions on gene activation in the astrocytes, allowing them to perform better under stress.
Protein Analysis to Understand Changes
To complete our investigations, we looked at how protein levels changed between the different kinds of astrocytes we studied. We found that TG2 deletion and VA4 treatment caused a mix of proteins to change. Interestingly, many of these proteins were connected to lipids and stress responses.
This shows that when TG2 is blocked or removed, the astrocytes change how they handle lipids and respond to stress, likely making them more supportive of nerve health.
Summary of Findings
Our research reveals a lot about how astrocytes respond to stress and the crucial role that TG2 plays in these processes. By blocking or removing TG2, astrocytes can better support the growth and recovery of nerve cells, especially in challenging environments.
The interactions between TG2 and Zbtb7a, and the effects on histone acetylation, provide new insights into the ways that astrocytes can help or hinder nerve recovery after injuries. Overall, we see that by tweaking TG2, we can help astrocytes become better champions for nerve health.
Why This Matters
Understanding the behavior of astrocytes and proteins like TG2 has important implications for treating nervous system injuries and diseases. If we can enhance the supportive nature of astrocytes, we might find new ways to improve recovery for people with spinal cord injuries or other nerve-related issues.
Ultimately, our work continues to unearth new insights about brain and spinal cord health and highlights the dynamic nature of astrocytes, which are often overlooked in discussions about nervous system function. As we continue our research, we hope to uncover even more ways to turn astrocytes into powerful allies for nerve health.
Conclusion
With all this knowledge in hand, the journey of understanding how astrocytes work is far from over. We've only scratched the surface, and there’s a whole universe of possibilities for future research. Who knew that brain cells could have such a flair for the dramatic? Whether through blocking specific proteins or promoting healthy growth in nerve cells, astrocytes are proving to be the unsung heroes of the nervous system-a little like the backup dancers who steal the show!
Title: Pharmacological inhibition of astrocytic transglutaminase 2 facilitates the expression of a neurosupportive astrocyte reactive phenotype in association with increased histone acetylation
Abstract: Astrocytes play critical roles in supporting structural and metabolic homeostasis in the central nervous system (CNS). CNS injury leads to the development of a range of reactive phenotypes in astrocytes whose molecular determinants are poorly understood. Finding ways to modulate astrocytic injury responses and leverage a pro-recovery phenotype holds promise in treating CNS injury. Recently, it has been demonstrated that ablation of astrocytic transglutaminase 2 (TG2) modulates the phenotype of reactive astrocytes in a way that improves neuronal injury outcomes both in vitro and in vivo. In an in vivo mouse model, pharmacological inhibition of TG2 with the irreversible inhibitor VA4 phenocopies the neurosupportive effects of TG2 deletion in astrocytes. In this study, we provide insights into the mechanisms by which TG2 deletion or inhibition result in a more neurosupportive astrocytic phenotype. Using a neuron-astrocyte co-culture model, we show that VA4 treatment improves the ability of astrocytes to support neurite outgrowth on an injury-relevant matrix. To better understand how pharmacologically altering TG2 affects its ability to regulate reactive astrocyte phenotypes, we assessed how VA4 inhibition impacts TG2s interaction with Zbtb7a, a transcription factor we have previously identified as a functionally relevant TG2 nuclear interactor. The results of these studies demonstrate that VA4 significantly decreases the interaction of TG2 and Zbtb7a. TG2s interactions with Zbtb7a, as well as a wide range of other transcription factors and chromatin regulatory proteins, suggest that TG2 may act as an epigenetic regulator to modulate gene expression. To begin to understand if TG2-mediated epigenetic modification may impact astrocytic phenotypes in our models, we interrogated the effect of TG2 deletion and VA4 treatment on histone acetylation and found significantly greater acetylation in both experimental groups. Consistent with these findings, previous RNA-sequencing and our present proteomic analysis also supported a predominant transcriptionally suppressive role of TG2 in astrocytes. Our proteomic data additionally unveiled pronounced changes in lipid and antioxidant metabolism in astrocytes with TG2 deletion or inhibition, which likely contribute to the enhanced neurosupportive function of these astrocytes.
Authors: Thomas Delgado, Jacen Emerson, Matthew Hong, Jeffrey W. Keillor, Gail VW Johnson
Last Update: 2024-10-31 00:00:00
Language: English
Source URL: https://www.biorxiv.org/content/10.1101/2023.02.06.527263
Source PDF: https://www.biorxiv.org/content/10.1101/2023.02.06.527263.full.pdf
Licence: https://creativecommons.org/licenses/by-nc/4.0/
Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.
Thank you to biorxiv for use of its open access interoperability.